The team identified more than 7,200 babies eligible to have received nirsevimab during its inaugural 2023-24 RSV season. But ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...

PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...

Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

Researchers are using optogenetics, the use of light to probe the functions of living tissue, to find new antiviral compounds ...

Our government supported 300,000 researchers at 2,500 university medical centers such as the Hospital of the University of Pennsylvania ...

Fiancé had a worrying week with her baby, Minthira. But now, it seems that she and David Toborowsky can breathe a bit easier.

The mobile health clinic, which was born out of the coronavirus pandemic, initially aimed to meet the increased demand for ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

In June, infectious disease physicians sounded the alarm over the Trump administration overstepping existing, transparent processes for changing vaccine recommendations, particularly pointing to new ...